Causes of Low Insulin Levels
Low insulin levels result primarily from autoimmune destruction of pancreatic beta-cells (type 1 diabetes), progressive beta-cell failure in type 2 diabetes, or rarely from paradoxical insulinoma presentations.
Primary Causes
Type 1 Diabetes (Autoimmune Beta-Cell Destruction)
The most common cause of truly low insulin levels is immune-mediated destruction of pancreatic beta-cells, which leads to little or no insulin secretion manifested by low or undetectable plasma C-peptide levels 1. This process:
- Occurs through autoimmune mechanisms with multiple genetic factors (particularly HLA-DQB1 and DRB1 haplotypes)
- Can present at any age, though most common in childhood and adolescence
- Progresses through three stages, with stage 3 representing complete beta-cell failure
- Results in absolute insulin deficiency requiring exogenous insulin for survival 1
The rate of beta-cell destruction varies considerably—rapid in infants and children (often presenting with DKA), slower in adults who may retain some function for years before becoming insulin-dependent 1.
Type 2 Diabetes (Relative Insulin Deficiency)
While type 2 diabetes classically involves insulin resistance, beta-cell dysfunction and progressive insulin deficiency are sine qua non for diabetes development 2. The insulin secretory deficit in type 2 diabetes is:
- Functionally severe but anatomically modest (20-40% reduction in beta-cell mass) 2
- Progressive and worsening with disease duration
- Partially acquired through glucotoxicity (hyperglycemia-induced reduced insulin biosynthesis) and lipotoxicity (elevated free fatty acids accelerating beta-cell apoptosis) 3, 4
- Demonstrable both at baseline and after stimulation 5
Critical distinction: Beta-cell dysfunction must be present for diabetes to occur, but insulin resistance determines whether this dysfunction manifests as overt diabetes 2.
Secondary and Rare Causes
Idiopathic Type 1 Diabetes
Some individuals develop permanent insulinopenia and DKA susceptibility without detectable autoantibodies or known etiology 1. This represents a distinct subgroup requiring the same insulin replacement as autoimmune type 1 diabetes.
Viral Triggers
Several viruses can damage beta-cells:
- Enteroviruses (Coxsackievirus B)
- SARS-CoV-2 (COVID-19), which increased cases of new-onset diabetes through direct beta-cell damage, immune-mediated destruction, or inflammatory cytokine effects 1
Checkpoint Inhibitor-Associated Diabetes
Patients receiving immune checkpoint inhibitors can develop rapid-onset type 1 diabetes, particularly those with predisposing HLA haplotypes 1. This cannot be predicted by family history or autoantibodies, requiring vigilant monitoring.
Paradoxical Insulinoma Presentation
A critical pitfall: Insulinomas can rarely present with inappropriately low measured insulin levels despite elevated C-peptide 6. This occurs because:
- The tumor may secrete proinsulin or insulin precursors
- C-peptide remains elevated, providing the diagnostic clue
- Hypoglycemia with low insulin but elevated C-peptide should prompt imaging for neuroendocrine tumors 6
Diagnostic Approach
When evaluating low insulin levels:
- Measure C-peptide simultaneously—this distinguishes true beta-cell failure from assay issues or paradoxical presentations 6
- Check for autoantibodies (GAD, IA-2, ZnT8, insulin autoantibodies) to identify autoimmune etiology 1
- Assess clinical context: DKA, age of onset, obesity status, family history
- Consider genetic testing in atypical presentations or family history suggesting monogenic diabetes 3
Key Clinical Pitfalls
- Don't assume obesity excludes type 1 diabetes—obesity is increasingly common in the general population and doesn't preclude autoimmune beta-cell destruction 1
- Don't dismiss low insulin with hypoglycemia—always check C-peptide to rule out insulinoma 6
- Don't attribute all low insulin to type 1 diabetes—progressive type 2 diabetes causes significant insulin deficiency requiring insulin therapy 2
- Monitor patients on checkpoint inhibitors regardless of diabetes risk factors, as onset can be rapid and unpredictable 1